Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1600-0536.1991.tb01704.x | DOI Listing |
J Cosmet Dermatol
January 2025
Department of Pharmaceutics, Faculty of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Background: Doxepin (DX) is used orally to relieve itching but can cause side effects like blurred vision, dry mouth, and drowsiness due to its antimuscarinic effect. To reduce these adverse effects and improve skin permeation, DX is being developed in topical formulations. This study aims to improve DX skin absorption by developing a microemulsion (ME) formulation (ME-DX).
View Article and Find Full Text PDFContact Dermatitis
January 2025
Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Contact Dermatitis
January 2025
Dermatology and Venereology Department, Hospital Santo António dos Capuchos, ULS São José, Lisbon, Portugal.
J Wound Ostomy Continence Nurs
January 2025
Meredith Sharp, MSN, RN, CWON, MEDSURG-BC, Wound Ostomy Nurse Department, Oklahoma Children's Hospital at OU Health, Oklahoma City, Oklahoma.
Purpose: The purpose of this quality improvement project was to implement and evaluate an algorithm for management and prevention of diaper dermatitis (DD) embedded in a scoring tool. The specific aim of the project was to decrease DD occurrences with a severity score of 3 to 4 by 25%.
Participants And Setting: Quality improvement participants comprised 164 neonates; 89 were cared for prior to project implementation and 75 post-implementation.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!